Detail akcie Fuji Pharma online

Business Summary: Fuji Pharma Co., Ltd. is a Japan-based company mainly engaged in the manufacture and sale of medical products. The Company is engaged in the manufacture and sale of hormone medicines for obstetrics and gynecology department, as well as injectable drugs for radiological department such as radiopaque dye for urinary tracts and blood vessels through its branches. In addition, the Company purchases its main pharmaceutical ingredients from its main parent company.
Financial Summary: BRIEF: For the six months ended 31 March 2025, Fuji Pharma Co Ltd revenues increased 13% to Y24.1B. Net income decreased 70% to Y1.29B. Revenues reflect Product segment increase of 13% to Y19.95B, Pharmaceutical contract manufacturing segment increase of 11% to Y4.15B. Net income was offset by SGA Expenses increase of 12% to Y7.58B (expense), Gain on valuation of derivatives decrease from Y733M (income) to Y0K.